Neurizon Therapeutics LimitedASX: NUZ

Dr Chris Bremer commences as Neurizon CEO

· Issued by Neurizon Therapeutics Limited via ASX

Filed with ASX · · 3 pages · English

Release

Neurizon Therapeutics Limited ABN 35 094 006 023 www.neurizon.com Suite 2, Level 11, 385 Bourke Street, Melbourne, VIC 3000 Tel: +61 3 9692 7222 Dr Chris Bremer commences as Neurizon Chief Executive Officer Highlights: ? Dr Chris Bremer has commenced as Chief Executive Officer, marking an...

Neurizon Therapeutics Limited on 6ix

Earlier from Neurizon Therapeutics

Later from Neurizon Therapeutics

All Neurizon Therapeutics news releases